Vedolizumab

27 trials 17 recruiting LOncology

Filter these 27 trials by condition, phase, country and more.

Open in Search →

27 Registered trials

17 Recruiting

7 Completed trials

17 Sponsors

25 Countries

Phase III

Phase II

Phase IV

Phase III: 11 Phase II: 5 Phase III/IV: 2 Phase IV: 9

Oversight events:

18 temporary halts across 1 trial

View oversight register →

Indications tested

Crohn's disease 7 Colitis ulcerative 3 Acute haemorrhagic ulcerative colitis 1 Pouchitis 1 Crohn´s disease 1

Sponsors using this IMP

Takeda Development Center Americas Inc. 8 Alimentiv Inc. 2 Amsterdam UMC Stichting 2 Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy 2 AbbVie Deutschland GmbH & Co. KG 1 Alvotech Swiss AG 1 Centre Hospitalier Universitaire Amiens Picardie 1 Centre Hospitalier Universitaire De Saint Etienne 1 Instytut Pomnik Centrum Zdrowia Dziecka 1 Isala Klinieken Stichting 1 Medical University Of Gdansk 1 Odense University Hospital 1

All trials — page 2

27 total

VERDICT - Optimal Treatment Target in Active Ulcerative Colitis (UC) Ended

2024-514183-21-00 Phase IV 5 countries Alimentiv Inc.
An extension study to investigate how safe Vedolizumab is in child patients with Ulcerative Colitis or Crohn's Disease Ended

2023-507766-35-00 Phase II 2 countries Takeda Development Center Americas Inc.
Evaluating the efficacy and safety of hyperbaric oxygen therapy as an adjuvant treatment compared to biologic therapy alone in moderate to s… Ended

2023-507450-32-00 Phase III 1 country Medical University Of Gdansk

Showing 25–27 of 27 trials

← All drugs A–Z